stockrow
Friday 6 November 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
59.84
1.44
−2.35%
Follow ATRC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 7 | 6 |
+8 more TTM periods Free account |
| 2.95% | 2.15% | (0.97%) | (2.40%) | ||
| 2.20% | 1.64% | (0.74%) | (1.81%) | ||
ROIC |
2.61% | 1.92% | (0.44%) | (1.48%) | |
Return on Tangible Assets |
4.30% | 3.45% | (1.64%) | (4.09%) | |
Average Days of Receivables |
47.11 | 51.25 | 47.14 | 45.51 | |
Free Cash Flow per Share |
1.08 | 1.09 | 1.11 | 1.01 | |
Free Cash Flow |
52.94 | 53.11 | 53.64 | 48.28 | |
Capital Expenditures |
(15.61) | (11.82) | (10.72) | (9.05) | |
| Other line items | |||||
Cash ROIC |
6.78% | 7.03% | 7.56% | 6.59% | |
Accounts Receivable Turnover |
8.48 | 7.80 | 8.20 | 8.42 | |
Accounts Payable Turnover |
2.60 | 4.39 | 4.83 | 5.31 | |
Inventory Turnover |
1.65 | 1.68 | 1.73 | 1.74 | |
Average Days of Payables |
213.52 | 96.92 | 82.81 | 69.07 | |
Days of Inventory on Hand |
232.32 | 226.89 | 219.88 | 214.20 | |
Tax Rate |
(0.08) | (0.13) | 0.41 | 0.13 | |
Research and Development Expense of Revenue |
18.19% | 17.21% | 18.28% | 18.56% | |
Selling, General and Administrative Expense of Revenue |
55.67% | 56.82% | 57.87% | 58.19% | |
Share Based Compensation of Revenue |
8.02% | 8.30% | 8.39% | 8.36% | |
Interest Coverage |
2.95 | 2.29 | (0.51) | (1.61) | |
Operating CF/Net income |
4.61 | 6.15 | (14.01) | (5.01) | |
Depreciation/Fixed assets |
0.00 | 0.50 | 0.53 | 0.54 | |
Capex/Depreciation |
0.00 | (0.55) | (0.51) | (0.43) | |
Revenue per Share |
12.06 | 11.70 | 11.42 | 11.19 | |
Operating CF per Share |
1.40 | 1.33 | 1.33 | 1.20 | |
Capex per Share |
(0.32) | (0.24) | (0.22) | (0.19) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026